Profil
Philippe Mendels-Flandre is the founder of Austral DX, serving as Chief Executive Officer since 2021.
Former positions include General Manager-Emerging Markets at Shire France SAS and Chief Operating Officer at Lysogene SA from 2017 to 2018.
Education includes an undergraduate degree from The Louvain School of Management.
Aktive Positionen von Philippe Mendels-Flandre
| Unternehmen | Position | Beginn |
|---|---|---|
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Vorstandsvorsitzender | 01.01.2021 |
Ehemalige bekannte Positionen von Philippe Mendels-Flandre
| Unternehmen | Position | Ende |
|---|---|---|
| LYSOGENE | Geschäftsführer | 15.11.2018 |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Philippe Mendels-Flandre
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
The Louvain School of Management
The Louvain School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Health Technology |
















